John W. Townsend's Insider Trades & SAST Disclosures

John W. Townsend's most recent trade in Unicycive Therapeutics Inc was a trade of 40,256 Stock Options done . Disclosure was reported to the exchange on Aug. 12, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Unicycive Therapeutics Inc
John W. Townsend Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Aug 2024 40,256 915,565 - - Stock Options
Unicycive Therapeutics Inc
John W. Townsend Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2024 228,119 875,309 - - Stock Options
Unicycive Therapeutics Inc
John W. Townsend Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2023 570,329 647,190 - - Stock Options
Unicycive Therapeutics Inc
John W. Townsend Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2022 35,000 76,861 - - Stock Options
Unicycive Therapeutics Inc
John W. Townsend Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2021 18,605 41,861 - - Stock Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades